My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Normosang 25 mg/ml, concentrate for solution for infusion



Recordati Rare DiseasesPA0928/001/001

Main Information

Trade NameNormosang 25 mg/ml, concentrate for solution for infusion
Active SubstancesHuman hemin
Dosage FormConcentrate for solution for infusion
Licence HolderRecordati Rare Diseases
Licence NumberPA0928/001/001

Group Information

ATC CodeB06AB Other hem products
B06AB01 hematin

Status

License statusAuthorised
Licence Issued11/06/1999
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceBatches marketed in Ireland shall be subject to control authority batch release in accordance with Article 114.2 of Directive 2001/83/EC as amended.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

HCP Guide
« Back
Follow medicine

Print